Zoledronic acid effective as treatment for bone complications in prostate cancer patients

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2002年 / 16卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1202 / 1202
页数：1
相关论文
共 50 条
  • [1] Preventing bone complications in patients with prostate cancer: The emerging role of zoledronic acid
    Saad, F
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (05) : 25 - 33
  • [2] Use of zoledronic acid in patients with prostate cancer bone metastases: control of pain and musculoskeletal complications
    Paparella, Stefano
    Finkelberg, Elisabetta
    Varisco, Daniela
    Tondelli, Elena
    Rocco, Francesco
    [J]. UROLOGIA JOURNAL, 2011, 78 (04) : 300 - 304
  • [3] Zoledronic acid compared with pamidronate in patients with prostate cancer and bone metastases: Effects on skeletal complications and bone markers
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 57 - 57
  • [4] Comparison between zoledronic acid and clodronate in the treatment of prostate cancer patients with bone metastases
    Wang, Feng
    Chen, Wei
    Chen, Hongde
    Mo, Licai
    Jin, Haiyong
    Yu, Zhixian
    Li, Chengdi
    Liu, Qing
    Duan, Feifei
    Weng, Zhiliang
    [J]. MEDICAL ONCOLOGY, 2013, 30 (03)
  • [5] Comparison between zoledronic acid and clodronate in the treatment of prostate cancer patients with bone metastases
    Feng Wang
    Wei Chen
    Hongde Chen
    Licai Mo
    Haiyong Jin
    Zhixian Yu
    Chengdi Li
    Qing Liu
    Feifei Duan
    Zhiliang Weng
    [J]. Medical Oncology, 2013, 30
  • [6] Jaw complications in breast and prostate cancer patients treated with zoledronic acid
    Ortega, C
    Faggiuolo, R
    Vormola, R
    Montemurro, F
    Nanni, D
    Goia, F
    Aglietta, M
    [J]. ACTA ONCOLOGICA, 2006, 45 (02) : 216 - 217
  • [7] Zoledronic acid for the treatment of prostate cancer
    Finianos, Antoine
    Aragon-Ching, Jeanny B.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (06) : 657 - 666
  • [8] Slow zoledronic acid releasing testis prostheses in the treatment of prostate cancer patients with bone metastases
    Serefoglu, Ege Can
    Balbay, M. Derya
    [J]. MEDICAL HYPOTHESES, 2009, 73 (03) : 387 - 388
  • [9] Zoledronic acid reduces bone resorption in patients with hormone prostate cancer
    Drudge-Coates, L.
    Rajbabu, K.
    Walsh, K.
    Thompson, P. M.
    Muir, G.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 98 - 98
  • [10] Administration of zoledronic acid before the onset of bone pain may be more effective in patients with bone metastases from prostate cancer
    Saad, F.
    Gleason, D.
    Chen, Y. M.
    Eastham, J.
    [J]. CANCER TREATMENT REVIEWS, 2006, 32 : S33 - S33
12345